Home » MORPOSYS AND ROCHE EXPAND THERAPEUTIC ANTIBODY PARTNERSHIP
MORPOSYS AND ROCHE EXPAND THERAPEUTIC ANTIBODY PARTNERSHIP
MorphoSys AG and Roche today announced a collaboration to develop new therapeutic
antibodies in oncology. Expanding on a September 2000 relationship in Alzheimer's
disease, Roche will elect new target molecules against which MorphoSys will
generate antibodies using its proprietary HuCAL GOLD technology.
WebWire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May